$The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts$

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts

Refractory Anemia with Ring Sideroblasts (RARS) is an acquired myelodysplastic syndrome (MDS) characterized by an excess iron accumulation in the mitochondria of erythroblasts. The pathogenesis of RARS and the cause of this unusual pattern of iron deposition remain unknown. We considered that the in...

Bibliografske podrobnosti
Main Authors:	Boultwood, J, Pellagatti, A, Nikpour, M, Pushkaran, B, Fidler, C, Cattan, H, Littlewood, T, Malcovati, L, Della Porta, MG, Jädersten, M, Killick, S, Giagounidis, A, Bowen, D, Hellström-Lindberg, E, Cazzola, M, Wainscoat, J
Format:	Journal article
Jezik:	English
Izdano:	Public Library of Science 2008

Podobne knjige/članki

The role of the iron transporter ABCB7 in refractory anemia with ring sideroblasts.
od: Jacqueline Boultwood, et al.
Izdano: (2008-04-01)

Gene expression profiling of CD34+ cells in patients with the 5q- syndrome.
od: Boultwood, J, et al.
Izdano: (2007)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: differences between early and advanced cases and analysis of apoptosis-related genes
od: Pellagatti, A, et al.
Izdano: (2007)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes (British Journal of Haematology (2008) 142, (57-64))
od: Pellagatti, A, et al.
Izdano: (2009)

Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
od: Pellagatti, A, et al.
Izdano: (2008)

Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes.
od: Pellagatti, A, et al.
Izdano: (2009)

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts
od: Nikpour, M, et al.
Izdano: (2013)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome.
od: Pellagatti, A, et al.
Izdano: (2011)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2010)

Deregulated Gene Expression Pathways in Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2009)

Marked down-regulation of nucleophosmin-1 is associated with advanced del(5q) myelodysplastic syndrome
od: Pellagatti, A, et al.
Izdano: (2011)

The transporter ABCB7 is a mediator of the phenotype of acquired refractory anemia with ring sideroblasts.
od: Nikpour, M, et al.
Izdano: (2013)

Mutation Analysis of TET2 Reveals the Clonal Nature of Refractory Anemia with Ring Sideroblasts
od: Malcovati, L, et al.
Izdano: (2010)

Gene expression profiling of erythroblasts from refractory anaemia with ring sideroblasts (RARS) and effects of G-CSF.
od: Nikpour, M, et al.
Izdano: (2010)

Molecular and clinical features of refractory anemia with ringed sideroblasts associated with marked thrombocytosis.
od: Malcovati, L, et al.
Izdano: (2009)

Deregulated gene expression pathways in myelodysplastic syndrome hematopoietic stem cells.
od: Pellagatti, A, et al.
Izdano: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2010)

Identification of Prognostic Markers by Gene Expression Profiling In Myelodysplastic Syndrome Hematopoietic Stem Cells
od: Pellagatti, A, et al.
Izdano: (2010)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes: Involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
od: Pellagatti, A, et al.
Izdano: (2006)

NEW INSIGHTS INTO THE BIOLOGY OF REFRACTORY ANEMIA WITH RING SIDEROBLASTS (RARS) AND IDENTIFICATION OF ERYTHROID G-CSF TARGETS BY GENE EXPRESSION PROFILING
od: Nikpour, M, et al.
Izdano: (2009)

Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, et al.
Izdano: (2009)

YI1 Gene expression profiling of day 7 erythroblasts from refractory anemia with ringed sideroblasts (RARS) and microarray-based identification of erythroid granulocyte-CSF (G-CSF) targets
od: Nikpour, M, et al.
Izdano: (2009)

Frequent Mutation of the Polycomb-Associated Gene ASXL1 in the Myelodysplastic Syndromes and in Acute Myeloid Leukaemia
od: Boultwood, J, et al.
Izdano: (2009)

Gene Expression Profiling of CD34(+) Cells in Patients with Myelodysplastic Syndromes
od: Pellagatti, A, et al.
Izdano: (2008)

Identification of gene expression-based prognostic markers in the hematopoietic stem cells of patients with myelodysplastic syndromes.
od: Pellagatti, A, et al.
Izdano: (2013)

Differential expression of genes related to JAK-STAT pathway activation or megakaryocyte differentiation/maturation in CD34+cells from patients with refractory anemia with ringed sideroblasts and thrombocytosis (RARS-T)
od: Malcovati, L, et al.
Izdano: (2007)

Frequent mutation of the polycomb-associated gene ASXL1 in the myelodysplastic syndromes and in acute myeloid leukemia.
od: Boultwood, J, et al.
Izdano: (2010)

COMPREHENSIVE ANALYSIS OF MUTATION STATUS, GENE EXPRESSION PROFILES, BLOOD AND BONE MARROW COUNTS AND OUTCOME IN PATIENTS WITH MYELODYSPLASTIC SYNDROMES
od: Pellagatti, A, et al.
Izdano: (2014)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridization (CGH).
od: Esoof, N, et al.
Izdano: (2006)

Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon-stimulated genes and correlation to FAB subtype and karyotype.
od: Pellagatti, A, et al.
Izdano: (2006)

Genome-wide analysis of copy number change and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density SNP arrays
od: Wang, L, et al.
Izdano: (2007)

Expression profiling of CD34+cells in patients with myelodysplastic syndromes with and without a del(5q)
od: Pellagatti, A, et al.
Izdano: (2005)

Somatic SF3B1 mutation in myelodysplasia with ring sideroblasts.
od: Papaemmanuil, E, et al.
Izdano: (2011)

Ring sideroblasts and sideroblastic anemias
od: Mario Cazzola, et al.
Izdano: (2011-06-01)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays.
od: Wang, L, et al.
Izdano: (2008)

Gene expression profiling of day 7 erythroblasts from RARS before and after treatment with G-CSF
od: Nikpour, M, et al.
Izdano: (2007)

Somatic Mutation of SF3B1, a Gene Encoding a Core Component of RNA Splicing Machinery, in Myelodysplasia with Ring Sideroblasts
od: Malcovati, L, et al.
Izdano: (2011)

Haploinsufficiency of RPS14 and Deregulation of Ribosomal- and Translation-Related Genes in MDS Patients with Del(5q)
od: Pellagati, A, et al.
Izdano: (2008)

Genome-wide analysis of copy number changes and loss of heterozygosity in myelodysplastic syndrome with del(5q) using high-density single nucleotide polymorphism arrays
od: Li Wang, et al.
Izdano: (2008-07-01)

High-resolution genomic profiling of myelodysplasia (MDS) by microarray comparative genomic hybridisation (CGH)
od: Esoof, N, et al.
Izdano: (2005)